genomic profiling to predict prognosis for patients with hr-smm
Published 7 months ago • 39 plays • Length 3:43Download video MP4
Download video MP3
Similar videos
-
0:52
genomic profiling at diagnosis of myeloid neoplasms
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
1:13
molecular mrd as a prognostic marker for aml patients with mutated cebpa
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
2:14
a new classification for identifying high-risk myeloma based on cytogenetic abnormalities
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
1:44
the genomics of rt and prognostic implications of rt characterization
-
3:23
molecular characteristics associated with increased risk of disease progression in smm
-
1:12
using biomarkers and genomics to inform treatment strategy in all
-
3:17
pet imaging to predict treatment outcomes: follow-up from the echelon-2 trial
-
1:36
identification of high-risk disease using molecular profiling by mymap
-
2:48
epigenetic profiling and machine learning for risk stratification in pediatric all
-
3:28
molecular prognostication in smm
-
1:25
genomic testing and therapeutic decisions in routine clinical practice in cll
-
2:06
introducing molecular diagnostics to improve leukemia care in developing countries
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy